Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FGPQY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,110
Award facts
- Contract value 100% obligated
- $13,110.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,110.02 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Cosentyx (secukinumab) 300mg dose in a 2-pen/mL configuration. The contract represents a firm fixed price delivery order with no set-aside designation, scheduled for completion by August 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as the company's primary vehicle for supplying pharmaceutical products and medical supplies to military and federal healthcare systems worldwide.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, maintains a significant role in the federal medical supply chain through its competitive awards with the Defense Logistics Agency. The company's portfolio demonstrates extensive capability in delivering specialty pharmaceuticals, including biologics like Cosentyx, which is used primarily for autoimmune and inflammatory conditions. This particular delivery order reflects routine pharmaceutical procurement supporting the Defense Health Agency and other federal healthcare beneficiaries within DLA's global supply network.
Quick answers
Who was awarded contract SPE2DB25FGPQY?
SPE2DB25FGPQY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FGPQY worth?
The government has obligated $13,110 on SPE2DB25FGPQY.
Is contract SPE2DB25FGPQY an order under another contract?
Yes. SPE2DB25FGPQY is a delivery order under SPE2DB24D2216, an indefinite delivery contract.
Was contract SPE2DB25FGPQY competed?
The extent of competition for SPE2DB25FGPQY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award